{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:02:59Z","timestamp":1768467779704,"version":"3.49.0"},"reference-count":22,"publisher":"The Journal of Rheumatology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.3899\/jrheum.2024-0122","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T13:25:44Z","timestamp":1709299544000},"page":"437-439","source":"Crossref","is-referenced-by-count":2,"title":["Flare in Systemic Lupus Erythematosus: Lost in Translation?"],"prefix":"10.3899","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9507-3338","authenticated-orcid":false,"given":"Eric F.","family":"Morand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9571-3289","authenticated-orcid":false,"given":"Sarah A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"key":"2024050105200564000_51.5.437.1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2023-0721"},{"key":"2024050105200564000_51.5.437.2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203310388445"},{"key":"2024050105200564000_51.5.437.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051135"},{"key":"2024050105200564000_51.5.437.4","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.132068"},{"key":"2024050105200564000_51.5.437.5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41584-023-00993-7","article-title":"Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforce","volume":"19","author":"Connelly","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2024050105200564000_51.5.437.6","unstructured":"US Food and Drug Administration . Patient-focused drug development guidance series for enhancing the incorporation of the patient\u2019s voice in medical product development and regulatory decision making. [Internet. Accessed February 8, 2024.] Available from: https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical"},{"key":"2024050105200564000_51.5.437.7","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316664593"},{"key":"2024050105200564000_51.5.437.8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0961203317722412","article-title":"Discordance of patient and physician health status concerns in systemic lupus erythematosus","volume":"27","author":"Golder","year":"2018","journal-title":"Lupus"},{"key":"2024050105200564000_51.5.437.9","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1093\/rheumatology\/keaa777","article-title":"Flares in patients with systemic lupus erythematosus","volume":"60","author":"McElhone","year":"2021","journal-title":"Rheumatology"},{"key":"2024050105200564000_51.5.437.10","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1007\/s11136-020-02572-9","article-title":"Patient-reported flare frequency is associated with diminished quality of life and family role functioning in systemic lupus erythematosus","volume":"29","author":"Katz","year":"2020","journal-title":"Qual Life Res"},{"key":"2024050105200564000_51.5.437.11","first-page":"275","article-title":"Patient-reported lupus flare symptoms are associated with worsened patient outcomes and increased economic burden","volume":"26","author":"Katz","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"key":"2024050105200564000_51.5.437.12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/acr.22971","article-title":"Effects of belimumab on flare rate and expected damage progression in patients with active systemic lupus erythematosus","volume":"69","author":"Iaccarino","year":"2017","journal-title":"Arthritis Care Res"},{"key":"2024050105200564000_51.5.437.13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrrheum.2018.2","article-title":"Systemic lupus erythematosus: Stress and the onset of SLE","volume":"14","author":"Morand","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2024050105200564000_51.5.437.14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216303"},{"key":"2024050105200564000_51.5.437.15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207744"},{"key":"2024050105200564000_51.5.437.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2015.05.010"},{"key":"2024050105200564000_51.5.437.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102858"},{"key":"2024050105200564000_51.5.437.18","doi-asserted-by":"crossref","first-page":"1034880","DOI":"10.3389\/fimmu.2022.1034880","article-title":"Type 1 interferon suppresses expression and glucocorticoid induction of glucocorticoid-induced leucine zipper (GILZ)","volume":"13","author":"Dankers","year":"2022","journal-title":"Front Immunol"},{"key":"2024050105200564000_51.5.437.19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215571"},{"key":"2024050105200564000_51.5.437.20","doi-asserted-by":"crossref","first-page":"e000031","DOI":"10.1136\/lupus-2014-000031","article-title":"Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials","volume":"1","author":"Furie","year":"2014","journal-title":"Lupus Sci Medicine"},{"key":"2024050105200564000_51.5.437.21","doi-asserted-by":"publisher","DOI":"10.7326\/M21-2078"},{"key":"2024050105200564000_51.5.437.22","doi-asserted-by":"publisher","DOI":"10.1177\/09612033211014267"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2024-0122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T15:02:43Z","timestamp":1714575763000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2024-0122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,1]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.3899\/jrheum.2024-0122"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2024-0122","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]}}}